Build Future-Ready Facilities with Strategic Expertise
At Indivirtus Healthcare Services Pvt. Ltd., our Feasibility & Planning services provide end-to-end support for pharmaceutical facility development. From site evaluation to ROI planning and regulatory mapping, we deliver robust, compliant roadmaps to ensure your Greenfield or Brownfield projects are scalable and future-ready.
Our services offer comprehensive feasibility studies, including technical and financial viability analysis, site selection, ROI forecasting, and regulatory risk mapping, ensuring GMP-compliant facility development.
Strategic planning ensures project viability, regulatory compliance, and optimized ROI, minimizing risks and aligning facility development with global standards for long-term success.
As a trusted CRO, Indivirtus Healthcare Services delivers expert-led planning solutions, guiding pharmaceutical companies to create scalable, compliant facilities with confidence and efficiency.
At Indivirtus Healthcare Services, our Feasibility & Planning services are led by seasoned consultants with global regulatory expertise. We conduct thorough technical and financial viability analyses, evaluate site suitability, and map regulatory risks to align with USFDA, EMA, and WHO standards. Our tailored roadmaps ensure your facility meets compliance and ROI objectives.
Our approach integrates data-driven insights and practical strategies, delivering scalable and future-ready plans that support Greenfield or Brownfield projects, ensuring regulatory readiness and operational efficiency.
Feasibility Assessment Report: Comprehensive analysis of project viability and risks.
Technical and Financial Analysis: Detailed evaluation of project feasibility and costs.
Site Evaluation Matrix: Structured assessment for optimal site selection.
Business Case with ROI Forecast: Strategic plan with financial projections.
Regulatory Risk Map: Framework for navigating global compliance requirements.
Our Feasibility & Planning services align with stringent global standards, ensuring your facility development is regulatory-compliant and ready for international markets. By adhering to industry-leading guidelines, we deliver solutions that enhance confidence and compliance.
Our Feasibility & Planning services are essential for pharmaceutical companies developing Greenfield or Brownfield projects. Ideal for site selection, regulatory alignment, and ROI optimization, our solutions support new facility setups, expansions, and compliance upgrades. Key use cases include planning GMP-compliant manufacturing sites, navigating regulatory requirements for global markets, and ensuring cost-effective project execution.
Indivirtus Healthcare Services is a trusted partner for pharmaceutical companies, delivering expert-led feasibility and planning solutions backed by certified consultants with global regulatory experience. Our services ensure scientifically defensible outcomes, rapid delivery, and strict confidentiality to protect your proprietary information.
With a commitment to industry best practices, we empower your facility development with robust, compliant, and scalable plans, driving regulatory success and long-term operational excellence.
It involves assessing engineering practicality, capacity planning, technology fit, cost modeling, CAPEX/OPEX estimation, and break-even analysis to determine project success probability.
Site selection includes evaluation based on proximity to suppliers, logistics, utility availability, workforce, regulatory requirements, and environmental risk to determine suitability.
A business case helps justify the investment by projecting costs, returns, timelines, and potential risks, enabling stakeholders to make informed go/no-go decisions.
It involves identifying all applicable local and international regulations (e.g., USFDA, EMA, WHO), zoning laws, permitting, and GxP requirements for facility setup and operations.
A standard feasibility and planning study for pharma facilities takes 4 to 6 weeks, depending on project complexity, data availability, and number of site options under consideration.
Our services include technical and financial viability analysis, site evaluation, ROI forecasting, regulatory risk mapping, and a comprehensive feasibility assessment to support GMP-compliant facility development.
Pharmaceutical companies developing Greenfield or Brownfield projects, seeking regulatory compliance, site selection, or ROI optimization benefit from our strategic planning solutions.
Our services align with ICH Q9, WHO TRS 1019 Annex 2, USFDA/EMA Facility Design Considerations, ISPE Baseline Guides, and EU GMP Annex 1, ensuring compliance with global regulatory standards.
Clients receive a feasibility assessment report, technical and financial analysis, site evaluation matrix, business case with ROI forecast, and a regulatory risk map.
Yes, our services are tailored to your project’s specific requirements, including site selection, regulatory needs, and financial goals, ensuring practical and compliant solutions.
We provide detailed financial analysis and ROI forecasting, aligning facility planning with cost-effective strategies to maximize returns while ensuring GMP compliance.